Download CY-1166
Transcript
On ly! MAPKAP-kinase 2 Assay/Inhibitor Screening Kit User’s Manual For Research Use Only, Not for use in diagnostic procedures Introduction Pu rp Measurement of MAPKAP-kinase 2 activity os e IAP kinase-activated protein kinase 2 (MAPKAP-kinase 2) was originally identified as a substrate for the p42/p44 MAPKs in vitro (1). However, recent data indicate that in intact cells, the upstream kinase that regulates MAPKAP-kinase 2 is p38 MAPK (2-5). Treatment of cells with endotoxin, interleukin-1, tumor necrosis factor, or various stress stimuli activate p38 MAPK and MAPKAP-kinase 2 (2-5). Mice deficient in MAPKAP-kinase 2 showed a reduction in bacterial lipopolysaccharide-induced biosynthesis of tumor necrosis factor (TNF), interferon, interleukin (IL)-1, IL-6, and nitric oxide (6), suggesting a critical role of MAPKAP-kinase 2 in inflammatory cytokine production. In human neutrophils MAPKAP-kinase 2 is also activated by the chemotactic factor fMet-Leu-Phe and phorbol 12-myristate 13-acetate (7). The function of MAPKAP-kinase 2 is not known, but its upstream kinase p38 MAPK has been proposed to be involved in the biosynthesis of inflammatory cytokines (8), apoptosis (9) and platelet aggregation (10). MAPKAP-kinase 2 contains a C-terminal autoinhibitory domain (10-13) and is activated by phosphorylation at multiple sites (12, 13). Recently It was reported that the major substrate for MAPKAP-kinase 2 in human neutrophils is not HSP27 but is a protein termed p60 (14), which we was identified as LSP1, a 339-amino acid cytoskeletal protein, the expression of which is restricted to neutrophils, lymphocytes, and macrophages. rR ef er en ce The protocol generally regarded as most sensitive for the quantitative measurement of MAPKAP-kinase 2 activity involves incubation of the MAPKAP-kinase 2 sample with substrate, either a natural or synthetic polypeptide (such as Long S6 Kinase substrate peptide), in the presence of Mg2+and 32P-labeled ATP. The reaction is terminated by "spotting" a sample onto a filter paper disc, followed by immersion in acid to precipitate the radiolabeled product. The filter papers are then washed extensively to remove unincorporated radiolabel and the radioactivity is counted. While sensitive, this method is labor-intensive, generates hazardous radioactive waste, and depends on a radioisotope of short half-life. It is particularly unsuitable when kinase assays are only performed on an infrequent basis. The CycLex Research Product CycLex MAPKAP-kinase 2 Assay/Inhibitor Screening Kit uses a peroxidase coupled anti-phospho-LSP1 serine204 monoclonal antibody as a reporter molecule in a 96-well ELISA format. This assay provides a non-isotopic, sensitive and specific method to detect MAPKAP-kinase 2 activity. Fo Cat#: CY-1166 2 Version#: 141028